ERBB2 and breast cancer: Regarding transcriptional aspects, KAT6A mRNA has been observed to be overexpressed in ER+ breast cancer, accounting for about 15% of breast cancers and a higher percentage of 22% in ER+/HER2− breast cancer [32].